Pages that link to "Q34074474"

The following pages link to Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics (Q34074474):

Displaying 26 items.

• Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy (Q26741506) (← links)
• Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice (Q33614675) (← links)
• ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets (Q34103656) (← links)
• Spinal muscular atrophy: from tissue specificity to therapeutic strategies (Q35029616) (← links)
• SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials (Q35949008) (← links)
• Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA. (Q36142393) (← links)
• Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy (Q36199822) (← links)
• Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy (Q36484406) (← links)
• Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy. (Q37094802) (← links)
• The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype (Q37231423) (← links)
• Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy (Q37238936) (← links)
• Advances in understanding the role of disease-associated proteins in spinal muscular atrophy. (Q38668630) (← links)
• SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons (Q40235775) (← links)
• Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy (Q41857431) (← links)
• Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative? (Q42002252) (← links)
• miRNA in spinal muscular atrophy pathogenesis and therapy (Q47379842) (← links)
• Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy. (Q49304342) (← links)
• Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy (Q49389328) (← links)
• Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice. (Q55369340) (← links)
• Impaired myogenic development, differentiation and function in hESC-derived SMA myoblasts and myotubes (Q57286077) (← links)
• Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice (Q57463072) (← links)
• Smooth muscle atrophy and colon pathology in SMN deficient mice (Q64227870) (← links)
• Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models (Q89626912) (← links)
• Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment (Q90555235) (← links)
• Muscle regulates mTOR dependent axonal local translation in motor neurons via CTRP3 secretion: implications for a neuromuscular disorder, spinal muscular atrophy (Q90728074) (← links)
• Abnormal fatty acid metabolism is a core component of spinal muscular atrophy (Q92554706) (← links)